Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Hope overshadowed – the US PrEP Summit

The US National HIV PrEP Summit, which took place in early December in San Francisco, was one of the most extraordinary HIV meetings I have

Published
31 January 2017
By
Gus Cairns
Queensland HIV Foundation uses health statistics to argue case against funding cut

A Queensland HIV foundation set up by the Newman government will lose its funding despite what it claims is its success in reducing the occurrence of the disease to the lowest level since 2008.

Published
31 January 2017
From
Sydney Morning Herald
Researchers identify drug that alleviates opioid withdrawal

(University of Calgary) Opioid use and abuse is a significant social, health and economic issue. Researchers at the University of Calgary's Faculty of Veterinary Medicine and Hotchkiss Brain Institute have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents. For their study, the researchers looked specifically at two common opioid drugs: morphine and fentanyl. Their work is leading to the development of a clinical trial in Calgary.

Published
30 January 2017
From
Eurekalert Medicine & Health
How Queensland Decreased HIV Notifications By 38 Percent In Two Years

Curiously, HIV's gone down but syphilis and gonorrhea are up.

Published
30 January 2017
From
Huffington Post Australia
What a Chemsex Clinic in Paris Taught Me About Saving Drug Users' Lives

Elements of harm reduction are effective and, like PrEP, they are all components of our toolkit. Education, psychotherapy, peer support and a host of other interventions must work in tandem. Can we really afford not to utilize every tool we have to prevent HIV and HCV? For me, keeping clients safe while I work with them to become abstinent is essential. It's not necessary to wait for an HIV and HCV "hotspot" like the one in Indiana to emerge before we take action. Let's check our moral outrage, become fully informed and use every tool possible. Countless lives are at stake.

Published
27 January 2017
From
The Body Pro
English High Court refers Truvada SPC case to EU Court of Justice

The English High Court has referred a supplementary protection certificate (SPC) dispute over Truvada (emtricitabine/tenofovir) to Europe’s highest court, the Court of Justice of the European Union (CJEU). The SPC if granted would effectively extend Gilead's patent rights over Truvada till 2020. If rejected Truvada's patent protection would expire at the same time as tenofovir's, i.e. this summer. For the full judgment, see http://www.bailii.org/ew/cases/EWHC/Patents/2017/13.html#para8

Published
27 January 2017
From
Life Sciences Intellectual Property Review (free subscription needed to read)
No new HIV infections in Northern California Kaiser PrEP programme, but STI rates rising

No new HIV infections have been seen among nearly 1000 people who started Truvada for pre-exposure prophylaxis (PrEP) at Kaiser Permanente Northern California, according to

Published
26 January 2017
By
Liz Highleyman
New and Touted HIV bNAb: Big deal or news blip?

Fervid research has uncovered dozens of antibodies that shield cells from HIV. Much work suggests broadly neutralizing antibodies hold promise as keys to HIV vaccine design or as immune therapy delivered by passive immunization or viral vectors. So what inspired the media handstands proclaiming the discovery of yet another bNAb?

Published
25 January 2017
From
AVAC
TAG Statement in Opposition to the Nomination of Tom Price for HHS Secretary

Tom Price’s questionable fitness to head a multi-agency cabinet-level department charged with the health of U.S. residents can simply be ascertained from his own record as a Congressional representative to parts of Atlanta’s northern suburbs – a district and metro area with extremely high rates of HIV and a flourishing opioid epidemic.

Published
24 January 2017
From
Treatment Action Group
Opportunities for addiction care and HIV prevention in Russia

The study estimated that providing methadone therapy to as few as 3% of people with opioid addiction would result in almost 50,000 Disability Adjusted Life Years (DALYs) averted, a substantial reduction in disease burden, over 10 years at a cost of just over $17 million USD.

Published
23 January 2017
From
Eurekalert Inf Dis

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.